Blue Owl Capital Holdings LP 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 4:20 pm Sale | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 5,089,015 5.540% | -1,268,913 (-19.96%) | Filing |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 6,357,928 8.480% | 2,266,810 (+55.41%) | Filing |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 4,091,118 8.480% | -1,320,172 (-24.40%) | Filing |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 5,411,290 7.220% | 5,411,290 (New Position) | Filing |